Turning Up the Volume in Back Bay
Samuels & Assoc.’s Rachel Diharce gives an inside look at how she and her team curated a unique retail experience at the new Lyrik development to cap off Boston’s iconic Newbury Street shopping district.
Samuels & Assoc.’s Rachel Diharce gives an inside look at how she and her team curated a unique retail experience at the new Lyrik development to cap off Boston’s iconic Newbury Street shopping district.
A Fenway commercial property added a major new tenant in Berklee School of Music, a neighborhood institution that’s had a rocky town-versus-gown relationship with residents and Boston officials.
Developers have also found an increasingly receptive audience with city leadership in Gateway Cities just outside Boston at a time when many point to an increasingly high cost of doing business within city limits.
Samuels & Assoc. and Lynn Mayor Jared Nicholson are seeking approval of a development agreement for an 850-unit apartment complex on a gateway waterfront parcel.
Boston Children’s Hospital has closed on its $172.5 million acquisition of a portion of a new life science tower to be developed in Boston’s Fenway neighborhood.
Boston Children’s Hospital will acquire nearly half of a new Fenway life science complex being developed by Alexandria Real Estate Equities and Samuels & Associates.
Who’s on the move? From new VPs to fresh project managers, see who’s been hired, promoted and honored: It’s the latest edition of Banker & Tradesman’s Personnel File.
There is never an off-season for the Fenway, one of Boston’s most authentic neighborhoods. More than 3,000 residential units are planned within 2 miles of The Fenway along with 4 million square feet of new office-lab space expected to deliver over the next five to 10 years.
As more Greater Boston communities adopt the state’s new opt-in energy code with its higher sustainability standards, developers are testing the limits of how far commercial buildings can effectively run without fossil fuel sources.
Attorneys for Suffolk Construction CEO John Fish won a round in the three-year legal battle against Boston developer Weiner Ventures over recent claims that the Boston developers destroyed evidence about the failed 1000 Boylston condominium project.
Boston is an attractive city with many desirable attributes, but it remains scarred by the 20th century public transportation project known as the Massachusetts Turnpike, an urban canyon that separates the Back Bay and South End.
In what looks to be an emerging trend, Boston’s mayor is leaning heavily on housing advocates for advice on highly-charged real estate issues, while excluding outspoken critics.
Developer Samuels & Assoc. hopes to transform the site of Boylston Street Star Market grocery store in Boston’s Fenway neighborhood into 553,000 square feet of office/lab and retail space.
A joint venture proposes a 550,000-square-foot life science building anchored by a 50,000-square-foot Star Market on a portion of the Landmark Center property in the Fenway.
The latest proposals for nearly 800,000 square feet of life science development in the Fenway are designed to meet the city of Boston’s goal of weaning commercial development off reliance on fossil fuels.
A well-capitalized life science developer will add a Kendall Square flavor to the Fenway with a pair of office-lab towers accelerating the growth of the neighborhood’s life science cluster.
Boston Mayor Marty Walsh’s pro-housing agenda delivered benefits to the city but critics say Walsh missed opportunities to make development more equitable and address the transportation and climate change crises.
An affiliate of Samuels & Assoc. is proposing a 273-unit apartment complex in Lower Allston that uses all-electric heating, cooling and hot water systems to reduce energy consumption.
Elkus Manfredi Architects recently completed an expansion of fitness wearables company WHOOP’s headquarters in Boston’s Fenway neighborhood to accommodate for the startup’s rapid growth.
Alexandria Real Estate Equities’ search for promising growth corridors for life science outside of Cambridge has led to the Fenway with a $1.52 billion agreement to buy Samuels & Assoc.’s 1.8-million-square-foot portfolio, including plans for an additional 400,000-square-foot office-lab building.